Hutchmed (HCM) reported H1 earnings Thursday of $2.61 per American depositary share, up from $0.15 a year earlier.
Total revenue for the six months ended June 30 was $277.7 million, compared with $305.7 million a year earlier.
As of June 30, the company said it had $1.36 billion in cash and cash equivalents and short-term investments compared with $836.1 million as of Dec. 31.
The company's shares were down 3.3% in recent premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.